NEW YORK (GenomeWeb News) — Tm Bioscience said yesterday that it has completed a private placement of unsecured subordinated debt and common share purchase warrants worth CA$6.24 million ($5.6 million)
The placement comes one day after the firm announced its second quarter financial results.  
Tm said it will use the proceeds to develop genetic tests and for general working capital purposes.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.